Hereditary Cancer

The integration of genetic tests in the clinical practice leads to a multitude of benefits for both patients as well as for their relatives in families with histories of hereditary cancer. These benefits include the early detection and prevention of cancer, the wider choice of prophylactic therapies, preventive surgical and other clinical interventions, the elimination of unnecessary screening, the lifting of the psychological burden of patient uncertainty, the provision of information for health-oriented lifestyles, family and career planning.
ASCO guidelines on the subject quote:

asco “As the leading organization representing cancer specialists involved in patient care and clinical research, the American Society of Clinical Oncology (ASCO) reaffirms its commitment to integrating cancer risk assessment and management, including molecular analysis of cancer predisposition genes, into the practice of oncology and preventive medicine.„
ASCO Policy Statement Update: Genetic Testing for Cancer Susceptibility, Journal of Clinical Oncology, 21, 1 (2003).

For hereditary cancer, BioGenomica offers all the established genetic tests including full sequencing of the following genes

Today, numerous medical associations worldwide acknowledge the cost-effectiveness of genetic testing for hereditary cancer, which provides true positive or negative results to individuals at-risk. (For more information as well as for instructions for sample preparation and posting, please contact BioGenomica).